Researchers at the University of Würzburg scanned 14 people with essential tremor (a shaking disorder closely related to Parkinson's tremor) who already had deep brain stimulation (DBS) implants in their thalamus. Each person was scanned twice using FDG-PET — a brain scan that measures how much energy (glucose) each region is consuming — once with the DBS switched on and once after it had been turned off for at least 72 hours. The team then compared those metabolic maps against a previously published "tremor treatment network": a brain-wide map, assembled from thousands of prior scans, showing which regions need to be engaged to relieve tremor. This is a small mechanistic imaging study, not a clinical trial, so the findings need replication in larger, Parkinson's-specific cohorts.
The key finding is that the local effect — how much the stimulation heated up brain activity right where the electrode sits — did not predict who improved most. What did predict improvement (accounting for about 59% of the variation between patients) was how closely the patient's whole-brain metabolic response matched the tremor treatment network. In other words, DBS works not by suppressing the thalamus locally but by sending a signal through a distributed circuit involving the motor cortex and cerebellum. Strikingly, those same regions were already overactive in patients when the DBS was off and tremor was present — meaning the circuit that generates tremor and the circuit that relieves tremor appear to be one and the same.
For people living with Parkinson's tremor, the practical implication is still several steps away, but the direction is important: the study supports a future in which the exact placement and programming of a DBS electrode is guided by how well it engages this specific network, rather than by anatomy alone. This could eventually help neurologists optimise DBS settings more precisely for tremor control. There is nothing to change in a patient's current care based on this paper — but if you or a family member is evaluating DBS for tremor, it is worth asking your neurologist whether your centre uses connectome-based targeting tools, as these are the clinical translation of the science described here.